Study of Dosage Exploration and Pharmacokinetics for HA121-28 Tablets
Condition(s):Advanced Solid TumorLast Updated:February 10, 2022Unknown status
Hide Studies Not Open or Pending
Condition(s):Advanced Solid TumorLast Updated:February 10, 2022Unknown status
Condition(s):Pancreatic CancerLast Updated:May 7, 2021Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:January 24, 2024Recruiting
Condition(s):Myelodysplastic SyndromesLast Updated:February 14, 2024Recruiting
Condition(s):Hematologic MalignanciesLast Updated:January 5, 2012Completed
Condition(s):Small Cell Lung Cancer (SCLC); Neuroendocrine (NE) Tumors; Large Cell Neuroendocrine (NE) TumorsLast Updated:October 17, 2019Withdrawn
Condition(s):Chemo-refractory Colorectal CarcinomaLast Updated:June 15, 2023Recruiting
Condition(s):CancersLast Updated:March 12, 2024Recruiting
Condition(s):Solid TumorLast Updated:September 13, 2021Completed
Condition(s):NeoplasmsLast Updated:May 6, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.